TriVascular has pioneered numerous design and manufacturing technologies in pursuit of our commitment to providing optimal solutions for endovascular repair (EVAR). The Ovation® Abdominal Stent Graft Platform is FDA-approved to treat the widest range of anatomies with an innovative, less invasive, clinically proven solution for patients with aortic disease.

Watch Video

Customized Seal

With the Ovation platform, the polymer-filled sealing rings create a custom seal and protect the aortic neck

The LUCY Study

The first prospective study evaluating endovascular aneurysm repair in a female population


TriVascular is an entrepreneurial company deeply committed to creating a work environment where excellence can live and grow

TriVascular News

18 November 2015: Endologix, Inc. and TriVascular Technologies, Inc. Announce Early Termination of Hart-Scott-Rodino Waiting Period in Connection With Proposed Merger

9 November 2015: TriVascular Technologies, Inc. Reports Third Quarter Financial Results

3 November 2015: Preliminary Results of the LIFE Study Presented at VIVA 2015